Pharmaceutical Technology

FEBRUARY 8, 2023

The 13 top players experienced significant growth over 2022 despite the decline in demand for COVID-19 vaccines and therapeutics, as well as uncertainty surrounding pricing due to the newly passed Inflation Reduction Act in the US. billion between Dec 31, 2021 and Dec 31, 2022, owing to expansion in its vaccine and oncology portfolio.

Vaccines 78

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 78

PharmaShots

MAY 9, 2023

Sit back and relax, while the article unfolds before you, the magic model that is certain to revamp your company Achieving economic sustenance and ensuring smooth sailing even in unfavorable situations are two common dreams that every pharmaceutical company shares.

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Drug Development Drug Pricing 56

pharmaphorum

JUNE 10, 2021

It goes without saying that if pharmaceutical companies are not profitable, they will not survive. Nowhere has this need for healthy companies been more apparent than during the current global coronavirus pandemic, with multiple manufacturers making COVID-19 vaccines rapidly available to the public. The Big Misconception.

Drug Pricing 105

Drug Pricing Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

APRIL 27, 2022

Trust in life science companies has fluctuated since the start of the pandemic. The reputation of COVID-19 vaccine makers understandably soared early on, as clinical trials were started and completed in record time, giving hopes to millions of people in lockdown. Especially, women tend to have more distrust in pharmaceutical companies.

Vaccines 98

Vaccines Drug Pricing Diabetes Pharmaceutical Companies 98

Pharmaceutical Technology

SEPTEMBER 26, 2022

Both Sandoz and Novartis are internationally renowned pharma companies, with a combined 34 production facilities worldwide. These highlight the parent company’s focus on innovative and high-value drug development. The company had revenues of $9.6bn both in 2020 and last year. The site employs around 250 people.

Biosimilars 64

Biosimilars Drug Development Vaccines Dosage 64

pharmaphorum

JANUARY 22, 2021

We don’t believe there will be draconian price cuts, for the same reason. The Biden administration could put additional scrutiny on drug prices, but more drastic measures, such as allowing Medicare to negotiate with pharma companies directly, are still unlikely.”. ” Science first.

Drug Pricing 63

Drug Pricing Packaging Biosimilars Pharmaceutical Companies 63

pharmaphorum

AUGUST 5, 2022

In addition to the climate provisions, however, the bill has a significant effect on prescription drug prices, and according to reports neither Manchin nor Sinema is objecting to these provisions, which are similar but not identical to the ones in the Build Back Better plan which previously passed in the House of Representatives.

Drug Pricing 111

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Vaccines 111